Boehringer Threatens Turkish Exit Due To Price Cuts
This article was originally published in PharmAsia News
Executive Summary
German drug maker Boehringer Ingelheim GMBH, dismayed by profit declines caused by a series of price cut measures enforced by the Turkish government, has indicated it is considering quitting the Turkish market, but it still hopes to continue research and investment in one of the fastest growing pharmaceutical markets